Helicobacter pylori eradication-treatment regimen + metformin

Helicobacter pylori eradication-treatment regimen + metformin has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Nov 15, 2026: “Effects of a Helicobacter pylori -directed treatment regimen combined with metformin on glycemic control and metabolic and inflammatory status in type 2 diabetes mellitus”.

Intervention

1 paper studies it2 findingsUpdated

1 new paper in 30 daysSee all 1 papers on helicobacter pylori eradication-treatment regimen + metformin

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Assignment to the Helicobacter pylori eradication-treatment regimen combined with metformin was associated with greater short-term glycated hemoglobin improvement than assignment to either regimen alone.”
Effects of a Helicobacter pylori -directed treatment regimen combined with metformin on glycemic control and metabolic and inflammatory status in type 2 diabetes mellitusThe Journal of international medical research2026doi:10.1177/03000605261501669

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave helicobacter pylori eradication-treatment regimen + metformin to people and measured what changed.

What changedDesignPeopleSource

down: Decreases glycated hemoglobinGreater reduction of 1.76 percentage points versus eradication-treatment regimen alone (95% CI 1.43–2.09) and 1.77 percentage points versus metformin alone (95% CI 1.41–2.13)

no change: Has no effect on complication incidence

Randomized trial6 months120 peopleadultType 2 diabetes mellitus and Helicobacter pylori infection; comparison with either regimen alone using archived summary dataThe Journal of international medical research, Nov 15, 2026

What did studies of helicobacter pylori eradication-treatment regimen + metformin find?

2

Studies of helicobacter pylori eradication-treatment regimen + metformin measured 2 outcomes: complication incidence and glycated hemoglobin.

Complication incidence

no changein humans1

1 study
  1. Helicobacter pylori eradication-treatment regimen + metformin showed no clear effect on complication incidence in humans Across the eradication-treatment regimen, metformin, and combined-treatment groups.

    “Complication incidence did not differ significantly among groups (P = 0.114).”

    Human trialAcross the eradication-treatment regimen, metformin, and combined-treatment groups6 monthsn = 120

    Effects of a Helicobacter pylori -directed treatment regimen combined with metformin on glycemic control and metabolic and inflammatory status in type 2 diabetes mellitus

    The Journal of international medical research

Glycated hemoglobin

downin humans1

1 study
  1. Helicobacter pylori eradication-treatment regimen + metformin decreases glycated hemoglobin in humans (Greater reduction of 1.76 percentage points versus eradication-treatment regimen alone (95% CI 1.43–2.09) and 1.77 percentage points versus metformin alone (95% CI 1.41–2.13)).

    “Assignment to the Helicobacter pylori eradication-treatment regimen combined with metformin was associated with greater short-term glycated hemoglobin improvement than assignment to either regimen alone.”

    Human trialType 2 diabetes mellitus and Helicobacter pylori infection; comparison with either regimen alone using archived summary data6 monthsn = 120

    Effects of a Helicobacter pylori -directed treatment regimen combined with metformin on glycemic control and metabolic and inflammatory status in type 2 diabetes mellitus

    The Journal of international medical research

More on Glycated hemoglobin

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months